thalidomide [clinicaltrials_resource:23d6d96310ed1929fa56f12c46b741ac]
intervention [clinicaltrials_vocabulary:intervention]
thalidomide [clinicaltrials_resource:23d6d96310ed1929fa56f12c46b741ac]
Bio2RDF identifier
23d6d96310ed1929fa56f12c46b741ac
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:23d6d96310ed1929fa56f12c46b741ac
arm group [clinicaltrials_vocabulary:arm-group]
intervention desc [clinicaltrials_vocabulary:intervention-desc]
Oral administration: Cycle 1 - ...... end of study treatment 200 mg.
intervention name [clinicaltrials_vocabulary:intervention-name]
thalidomide
other name [clinicaltrials_vocabulary:other-name]
Thalidomid
identifier
clinicaltrials_resource:23d6d96310ed1929fa56f12c46b741ac
title
thalidomide
@en
type
label
thalidomide [clinicaltrials_resource:23d6d96310ed1929fa56f12c46b741ac]
@en